Sitaxentan sodium salt
SIGMA/PZ0203 - ≥98% (HPLC)
Synonym: N-
CAS Number: 210421-74-2
Empirical Formula (Hill Notation): C18H14ClN2NaO6S2
Molecular Weight: 476.89
Linear Formula: C18H14ClN2NaO6S2
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to beige |
| form | powder |
| InChI | 1S/C18H14ClN2O6S2.Na/c1-9 |
| InChI key | MDTNUYUCUYPIHE-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | [Na+].Cc1cc2OCOc2cc1CC(=O |
| solubility | H2O: 10 mg/mL (clear solution) |
| storage temp. | room temp |
| Biochem/physiol Actions: | Sitaxentan (Sitaxsentan) is a potent and selective endothelin ET(A) receptor antagonist once used in the treatment of pulmonary arterial hypertension (PAH), but removed from the market because of hepatotoxicity. It is over 6000-fold selective for the the ETA receptor subtype with an IC50 of 1 nM for ETA versus an IC50 of 9800 nM for ETB. |
| Biochem/physiol Actions: | Sitaxentan is a potent and selective endothelin ET(A) receptor antagonist; antihypertensive. |
| Biochem/physiol Actions: | Sitaxsentan prevents shunt mediated elevation of pulmonary vascular resistance (PVR). Sitaxsentan effectively inhibits basolateral Na+-taurocholate cotransporting polypeptide (NTCP), organic anion-transporting polypeptides (OATPs) and bile salt export pump (BSEP). |
| Packaging: | 5, 25 mg in glass bottle |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | room temp |
| UNSPSC | 51111800 |

